SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-25-013175 from Vyome Holdings, Inc (HIND)

Vyome Holdings, Inc
Date: Feb. 13, 2025 · CIK: 0001427570 · Accession: 0001104659-25-013175

AI Filing Summary & Sentiment

File numbers found in text: 333-284362

Date
February 13, 2025
Author
/s/ Paul F. Hickey
Form
CORRESP
Company
Vyome Holdings, Inc

Letter

February 13, 2025

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, NE

Washington, DC 20549

Attn: Doris Stacey Gama

Re: ReShape Lifesciences Inc.

Registration Statement on Form S-1

File No. 333-284362

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended, ReShape Lifesciences Inc. (the “Registrant”) hereby respectfully requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time, on February 14, 2025, or as soon thereafter as is practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Fox Rothschild LLP, counsel to the Registrant, to orally modify or withdraw this request for acceleration.

The Registrant requests that it be notified of such effectiveness by a telephone call to Brett Hanson of Fox Rothschild LLP at (612) 607-7330.

Thank you for your assistance in this matter. Should you have any questions, please call Mr. Hanson.

Very truly yours,
/s/ Paul F. Hickey

Show Raw Text
CORRESP
1
filename1.htm

February 13, 2025

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, NE

Washington, DC 20549

Attn: Doris Stacey Gama

    Re:
    ReShape Lifesciences Inc.

    Registration Statement on Form S-1

    File No. 333-284362

    Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended,
ReShape Lifesciences Inc. (the “Registrant”) hereby respectfully requests that the effective date of the above-referenced
registration statement be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time, on February 14, 2025, or
as soon thereafter as is practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to
the staff of the Commission. The Registrant hereby authorizes Fox Rothschild LLP, counsel to the Registrant, to orally modify or withdraw
this request for acceleration.

The Registrant requests that it be notified of such effectiveness by
a telephone call to Brett Hanson of Fox Rothschild LLP at (612) 607-7330.

Thank you for your assistance in this matter. Should you have any questions,
please call Mr. Hanson.

Very truly yours,

    /s/ Paul F. Hickey

Paul F. Hickey

Chief Executive Officer